Profile | GDS5420 / 213289_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 218.46 | 54 |
GSM1296119 | B_lesional_pre-dose | 731.82 | 74 |
GSM1296076 | C_lesional_pre-dose | 497.57 | 69 |
GSM1296092 | D_lesional_pre-dose | 439.23 | 66 |
GSM1296103 | E_lesional_pre-dose | 254.17 | 56 |
GSM1296078 | F_lesional_pre-dose | 604.79 | 72 |
GSM1296107 | G_lesional_pre-dose | 702.14 | 74 |
GSM1296109 | H_lesional_pre-dose | 440.19 | 65 |
GSM1296080 | I_lesional_pre-dose | 111.12 | 45 |
GSM1296090 | J_lesional_pre-dose | 462.46 | 67 |
GSM1296074 | K_lesional_pre-dose | 493.54 | 69 |
GSM1296111 | L_lesional_pre-dose | 832.29 | 76 |
GSM1296099 | M_lesional_pre-dose | 352.08 | 61 |
GSM1296086 | O_lesional_pre-dose | 391.42 | 64 |
GSM1296117 | P_lesional_pre-dose | 817.14 | 76 |
GSM1296113 | Q_lesional_pre-dose | 770.45 | 75 |
GSM1296096 | R_lesional_pre-dose | 388.75 | 63 |
GSM1296105 | S_lesional_pre-dose | 294.34 | 58 |
GSM1296098 | T_lesional_pre-dose | 225.24 | 54 |
GSM1296101 | U_lesional_pre-dose | 222.55 | 54 |
GSM1296121 | V_lesional_pre-dose | 722.91 | 74 |
GSM1296088 | W_lesional_pre-dose | 241.54 | 56 |
GSM1296082 | X_lesional_pre-dose | 583.76 | 71 |
GSM1296115 | Y_lesional_pre-dose | 832.8 | 76 |
GSM1296084 | Z_lesional_pre-dose | 276.7 | 58 |
GSM1296072 | B_lesional_day8 | 629.98 | 72 |
GSM1296069 | L_lesional_day8 | 898.17 | 78 |
GSM1296071 | P_lesional_day8 | 579.41 | 70 |
GSM1296070 | Y_lesional_day8 | 726.79 | 74 |
GSM1296073 | V_lesional_day8 | 724.86 | 74 |
GSM1296034 | A_lesional_day15 | 141.66 | 46 |
GSM1296041 | G_lesional_day15 | 765.13 | 75 |
GSM1296035 | R_lesional_day15 | 262.49 | 57 |
GSM1296038 | U_lesional_day15 | 342.66 | 61 |
GSM1296047 | B_lesional_day15 | 604.03 | 71 |
GSM1296039 | E_lesional_day15 | 501.68 | 68 |
GSM1296042 | H_lesional_day15 | 650.05 | 72 |
GSM1296043 | L_lesional_day15 | 704.41 | 73 |
GSM1296037 | M_lesional_day15 | 284.69 | 58 |
GSM1296046 | P_lesional_day15 | 773.53 | 75 |
GSM1296044 | Q_lesional_day15 | 720.96 | 74 |
GSM1296045 | Y_lesional_day15 | 764.84 | 75 |
GSM1296025 | C_lesional_day15 | 126.39 | 45 |
GSM1296033 | D_lesional_day15 | 302.23 | 59 |
GSM1296027 | I_lesional_day15 | 176.54 | 52 |
GSM1296032 | J_lesional_day15 | 313.45 | 59 |
GSM1296024 | K_lesional_day15 | 108.5 | 44 |
GSM1296031 | W_lesional_day15 | 309.9 | 59 |
GSM1296028 | X_lesional_day15 | 288.57 | 59 |
GSM1296029 | Z_lesional_day15 | 211.73 | 53 |
GSM1296026 | F_lesional_day15 | 174.46 | 51 |
GSM1296030 | O_lesional_day15 | 138.79 | 49 |
GSM1296040 | S_lesional_day15 | 227.66 | 54 |
GSM1296036 | T_lesional_day15 | 266.71 | 56 |
GSM1296048 | V_lesional_day15 | 656.46 | 72 |
GSM1296059 | A_lesional_day43 | 219.54 | 54 |
GSM1296066 | G_lesional_day43 | 791.68 | 75 |
GSM1296060 | R_lesional_day43 | 365.96 | 62 |
GSM1296063 | U_lesional_day43 | 451.33 | 66 |
GSM1296064 | E_lesional_day43 | 590.47 | 71 |
GSM1296067 | H_lesional_day43 | 470.58 | 66 |
GSM1296062 | M_lesional_day43 | 170.85 | 50 |
GSM1296068 | Q_lesional_day43 | 748.23 | 74 |
GSM1296050 | C_lesional_day43 | 337.12 | 61 |
GSM1296057 | D_lesional_day43 | 324.8 | 60 |
GSM1296052 | I_lesional_day43 | 203.19 | 54 |
GSM1296054 | J_lesional_day43 | 269.38 | 56 |
GSM1296049 | K_lesional_day43 | 149.63 | 48 |
GSM1296055 | W_lesional_day43 | 310.31 | 59 |
GSM1296053 | X_lesional_day43 | 192.05 | 52 |
GSM1296058 | Z_lesional_day43 | 199.41 | 53 |
GSM1296051 | F_lesional_day43 | 406.87 | 65 |
GSM1296056 | O_lesional_day43 | 277.83 | 59 |
GSM1296065 | S_lesional_day43 | 563.36 | 70 |
GSM1296061 | T_lesional_day43 | 177.2 | 50 |
GSM1296095 | A_non-lesional_pre-dose | 485.19 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 722.56 | 74 |
GSM1296077 | C_non-lesional_pre-dose | 122.13 | 45 |
GSM1296093 | D_non-lesional_pre-dose | 141.33 | 46 |
GSM1296104 | E_non-lesional_pre-dose | 662.24 | 73 |
GSM1296079 | F_non-lesional_pre-dose | 213.16 | 54 |
GSM1296108 | G_non-lesional_pre-dose | 674.84 | 73 |
GSM1296110 | H_non-lesional_pre-dose | 559.96 | 69 |
GSM1296081 | I_non-lesional_pre-dose | 83.79 | 40 |
GSM1296091 | J_non-lesional_pre-dose | 501.56 | 68 |
GSM1296075 | K_non-lesional_pre-dose | 507.63 | 69 |
GSM1296112 | L_non-lesional_pre-dose | 700.4 | 73 |
GSM1296100 | M_non-lesional_pre-dose | 309.16 | 59 |
GSM1296087 | O_non-lesional_pre-dose | 223.59 | 56 |
GSM1296118 | P_non-lesional_pre-dose | 766.07 | 75 |
GSM1296114 | Q_non-lesional_pre-dose | 732.14 | 74 |
GSM1296097 | R_non-lesional_pre-dose | 377.47 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 380.06 | 62 |
GSM1296102 | U_non-lesional_pre-dose | 215.26 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 760.76 | 75 |
GSM1296089 | W_non-lesional_pre-dose | 355.22 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 108.13 | 43 |
GSM1296116 | Y_non-lesional_pre-dose | 832.44 | 76 |
GSM1296085 | Z_non-lesional_pre-dose | 272.08 | 57 |